igantet
instituto grifols s.a. - immunoglobulina tetanica - immunoglobulina tetanica
igamad
instituto grifols s.a. - immunoglobulina anti-d (rh) - immunoglobulina anti-d (rh)
igantibe
instituto grifols s.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
neohepatect
biotest pharma gmbh - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
keyvenb
kedrion s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
niuliva
instituto grifols s.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
rhesonativ
octapharma italy s.p.a. - immunoglobulina anti-d (rh) - immunoglobulina anti-d (rh)
vebiked
kedrion s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
kedhbs
kedrion s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
hizentra
csl behring gmbh - immunoglobulina umana normale (scig) - sindromi da immunodeficienza immunologica - sieri immuni e immunoglobuline, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.